|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Nova Minerals Secures Prime Site for U.S. Antimony Refinery, Targets Military-Grade Production in 2026
Nova Minerals (Nasdaq: NVA) has secured a 42.81-acre industrial site at Alaska’s Port MacKenzie for its proposed antimony refinery, a critical step toward establishing the first fully integrated U.S. supply chain for military-spec antimony. Backed by a $43.4M award from the U.S. Department of War and strong state support, Nova is fast-tracking Phase 1 production, with first deliveries targeted within 24 months, positioning the company as a key player in national defense and industrial supply chains.
|
|
|
|
Nexalin’s Gen-2 SYNC Device Shows Breakthrough Alzheimer’s Results in Peer-Reviewed Study
Nexalin Technology (Nasdaq: NXL) published compelling clinical results in Radiology showing its 40-Hz Gen-2 SYNC DIFS™ neurostimulation device significantly improves cognitive function and brain connectivity in mild Alzheimer’s patients, without drugs or side effects. The sham-controlled study validates the device’s mechanism via fMRI and strengthens Nexalin’s global strategy to capture a share of the $20B Alzheimer’s market with its non-invasive, deep-brain neurostimulation technology.
|
|
|
|
|
New Era Advances Flagship AI Data Center to Phase Two Engineering, Strengthens Balance Sheet
New Era Energy & Digital (Nasdaq: NUAI) kicked off Phase Two engineering for its West Texas-based Texas Critical Data Center (TCDC), a joint venture targeting scalable AI and GPU infrastructure with plans to exceed 1 GW capacity. With land holdings expanding to 438 acres and streamlined air permitting underway, the project is on track for 2026 construction. A recent 8-K filing also revealed the retirement of convertible notes and improved financial flexibility, reinforcing New Era’s disciplined execution and long-term vision in next-gen digital infrastructure.
|
|
|
|
|
|
|
Bimergen Secures $200M Equity Commitment to Accelerate 2 GW Battery Storage Pipeline
Bimergen Energy (OTCQB: BESS) landed a transformative equity commitment of up to $200 million from a leading European energy firm to fund its utility-scale battery energy storage projects across the U.S. An previously announced initial $10 million will jumpstart early-stage development, supporting Bimergen’s rapidly advancing 2 GW project pipeline and reinforcing its position in the high-growth grid resilience and energy storage market.
|
|
|
|
|
NioCorp Secures Final Land for Elk Creek Critical Minerals Project, Clearing Path to Construction
NioCorp Developments (Nasdaq: NB) has acquired the final 325.77 acres needed to fully control the Elk Creek Project site in Nebraska, securing all surface and mineral rights required to begin construction upon project financing. With a 38-year mine life and future expansion potential, Elk Creek is positioned to become a major U.S. source of niobium, scandium, titanium, and rare earths vital to defense, clean energy, and high-performance manufacturing.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Lantern Pharma Inc. (NASDAQ: LTRN) & Enlivex Therapeutics Ltd. (NASDAQ: ENLV)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates

| Company |
Rating |
Price Target |
Firm |
Report Date |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
|

|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
FatPipe (NASDAQ: FATN)
4:15pm Eastern
FatPipe, Inc. (Nasdaq: FATN) is a pioneer in secure, software-defined networking technologies that simplify and fortify enterprise connectivity.
|
|
|
|
Jackpot Digital (OTCQB: JPOTF)
4:15pm Eastern
Jackpot Digital Inc. is the leading provider of electronic poker table games, offering innovative gaming solutions to casinos worldwide.
|
|
|
|
60 Degrees Pharmaceuticals (NASDAQ: SXTP)
04:15pm Eastern
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
|
|
|
|
Archived Events
|
|
|
BioVie (NASDAQ: BIVI)
4:15pm Eastern
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer's disease, Parkinson’s disease and long COVID) and advanced liver disease.
|
|
|
|
Quote of the Week
|
"How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case."
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Buying is only half the equation. You also need to know when to sell.
|
|
|
|
|
|
|